These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8779541)

  • 21. Mutations at codon 249 of p53 gene in human hepatocellular carcinomas from Tongan, China.
    Yang M; Zhou H; Kong RY; Fong WF; Ren LQ; Liao XH; Wang Y; Zhuang W; Yang S
    Mutat Res; 1997 Nov; 381(1):25-9. PubMed ID: 9403027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas.
    Hosono S; Chou MJ; Lee CS; Shih C
    Oncogene; 1993 Feb; 8(2):491-6. PubMed ID: 8093978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular mechanism of hepatocarcinogenesis.
    Sheu JC
    J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S309-13. PubMed ID: 9407351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the p53 tumor-suppressor gene in hepatocellular carcinomas from Britain.
    Challen C; Lunec J; Warren W; Collier J; Bassendine MF
    Hepatology; 1992 Dec; 16(6):1362-6. PubMed ID: 1332921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allele-specific PCR analysis of p53 codon 249 AGT transversion in liver tissues from patients with viral hepatitis.
    Kirby GM; Batist G; Fotouhi-Ardakani N; Nakazawa H; Yamasaki H; Kew M; Cameron RG; Alaoui-Jamali MA
    Int J Cancer; 1996 Sep; 68(1):21-5. PubMed ID: 8895534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 mutations and aflatoxin B1 exposure in hepatocellular carcinoma patients from Thailand.
    Hollstein MC; Wild CP; Bleicher F; Chutimataewin S; Harris CC; Srivatanakul P; Montesano R
    Int J Cancer; 1993 Jan; 53(1):51-5. PubMed ID: 8380058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
    Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
    J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Co-inactivation of the p53 and RB genes in human hepato cellular carcinoma].
    Murakami Y
    Nihon Rinsho; 1993 Feb; 51(2):375-9. PubMed ID: 8096551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations.
    Rashid A; Wang JS; Qian GS; Lu BX; Hamilton SR; Groopman JD
    Br J Cancer; 1999 Apr; 80(1-2):59-66. PubMed ID: 10389978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Aberrations of tumor suppressor genes in hepatocellular carcinomas].
    Fujimoto Y
    Hokkaido Igaku Zasshi; 1994 Sep; 69(5):1252-60. PubMed ID: 7868063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of heterozygosity and analysis of mutation of p53 in hepatocellular carcinoma.
    Yumoto Y; Hanafusa T; Hada H; Morita T; Ooguchi S; Shinji N; Mitani T; Hamaya K; Koide N; Tsuji T
    J Gastroenterol Hepatol; 1995; 10(2):179-85. PubMed ID: 7540433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma.
    Kirk GD; Lesi OA; Mendy M; Szymañska K; Whittle H; Goedert JJ; Hainaut P; Montesano R
    Oncogene; 2005 Sep; 24(38):5858-67. PubMed ID: 16007211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53 gene mutation spectrum in hepatocellular carcinomas in Hong Kong Chinese.
    Ng IO; Chung LP; Tsang SW; Lam CL; Lai EC; Fan ST; Ng M
    Oncogene; 1994 Mar; 9(3):985-90. PubMed ID: 8108145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absence of mutations in the p53 tumor suppressor gene in woodchuck hepatocellular carcinomas associated with hepadnavirus infection and intake of aflatoxin B1.
    Rivkina M; Cote PJ; Robinson WS; Tennant BC; Marion PL
    Carcinogenesis; 1996 Dec; 17(12):2689-94. PubMed ID: 9006107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation.
    Volkmann M; Hofmann WJ; Müller M; Räth U; Otto G; Zentgraf H; Galle PR
    Oncogene; 1994 Jan; 9(1):195-204. PubMed ID: 8302580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
    Xue KX
    Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53 mutation in HCV-genotype-4 associated hepatocellular carcinoma in Egyptian patients.
    Zekri AR; Bahnassy AA; Madbouly MS; Asaad NY; El-Shehaby AM; Alam El Din HM
    J Egypt Natl Canc Inst; 2006 Mar; 18(1):17-29. PubMed ID: 17237848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
    Yoon YJ; Chang HY; Ahn SH; Kim JK; Park YK; Kang DR; Park JY; Myoung SM; Kim DY; Chon CY; Han KH
    Carcinogenesis; 2008 Jun; 29(6):1192-6. PubMed ID: 18390844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutational hotspot in the p53 gene in human hepatocellular carcinomas.
    Hsu IC; Metcalf RA; Sun T; Welsh JA; Wang NJ; Harris CC
    Nature; 1991 Apr; 350(6317):427-8. PubMed ID: 1849234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet.
    Hsia CC; Kleiner DE; Axiotis CA; Di Bisceglie A; Nomura AM; Stemmermann GN; Tabor E
    J Natl Cancer Inst; 1992 Nov; 84(21):1638-41. PubMed ID: 1279184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.